Fig. 4From: A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapyThe IncRNA signature predicts the overall survival of patients with OC. a. Kaplan-Meier survival curves classified patients into high- and low-risk groups on the base of their lncRNA signatures in the sample datasets. P-values were determined through the log-rank test. b. Results of receiver operating characteristic (ROC) analysisBack to article page